| Dr Drew Maygren, DO | |
|
14502 W Meeker Blvd, Sun City West, AZ 85375-5282 | |
| (623) 524-4000 | |
| Not Available |
| Full Name | Dr Drew Maygren |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 14 Years |
| Location | 14502 W Meeker Blvd, Sun City West, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568783769 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 20A17282 (California) | Primary |
| 2084P0805X | Psychiatry & Neurology - Geriatric Psychiatry | 006645 (Arizona) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Researchers at Otago University say that more than a third of middle-aged New Zealand women eat fast and this tendency could be leading to increased weight gain. The advice "eat slowly, eat less" has been around for decades but, unlike many dieting myths, this one seems to hold water.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 4 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Researchers at Otago University say that more than a third of middle-aged New Zealand women eat fast and this tendency could be leading to increased weight gain. The advice "eat slowly, eat less" has been around for decades but, unlike many dieting myths, this one seems to hold water.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Drew Maygren, DO 3900 Broadway, Oakland, CA 94611-5616 Ph: (510) 752-1075 | Dr Drew Maygren, DO 14502 W Meeker Blvd, Sun City West, AZ 85375-5282 Ph: (623) 524-4000 |
News Archive
Sinovac Biotech Ltd. ( SVA), a leading developer and provider of vaccines, announced today that it executed a joint venture (JV) agreement to establish Sinovac (Dalian) Vaccine Technology Co., Ltd. (Sinovac Dalian). The JV will research, develop, produce and commercialize human-use vaccines. Sinovac will contribute its expertise and experience in developing and commercializing world-class vaccines; the other party will bring its land use rights, manufacturing facilities and established operating infrastructure.
Mammography Reporting System, Inc. (MRS) will demonstrate their newest high risk indicator at RSNA 2009, in Chicago. MRS is the only company in the industry offering three separate high risk indicators to alert radiologists of potentially at-risk patients at the very point they interpret a mammogram.
Researchers at Otago University say that more than a third of middle-aged New Zealand women eat fast and this tendency could be leading to increased weight gain. The advice "eat slowly, eat less" has been around for decades but, unlike many dieting myths, this one seems to hold water.
Affymax, Inc. today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies' exclusive global agreement to develop and commercialize Hematide™, Affymax's investigational drug for the treatment of anemia in chronic renal failure patients. The milestone was achieved with the initiation of Phase 3 clinical testing of Hematide to treat anemia in chronic renal failure patients in Japan.
› Verified 4 days ago
Vardges Vandian, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14520 W Granite Valley Dr, Suite 210, Sun City West, AZ 85375 Phone: 866-974-2673 Fax: 866-939-2673 | |
Dr. Kimberlee Van Wilson, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14502 W Meeker Blvd, Sun City West, AZ 85375 Phone: 632-524-4143 | |
Dr. David Carlos Morales, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 14300 W Granite Valley Dr Ste A1, Sun City West, AZ 85375 Phone: 623-777-4747 | |
Paul Raymond Butzine, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 14506 W Granite Valley Dr, Ste 221, Sun City West, AZ 85375 Phone: 623-214-1141 Fax: 623-214-8903 | |
Dr. Philip G Vitelli, DO Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 15801 W Huron Dr, Sun City West, AZ 85375 Phone: 623-570-0511 Fax: 623-223-5665 |